Patient Resources
Practical information
Safety Profile
Below is a selection of the observed side effects. Please refer to the SmPc for the complete list.
The most common adverse reactions of any grade (incidence ≥20%) in patients receiving asciminib were musculoskeletal pain (37.1%), upper...Twitter Linkedin Facebook Pinterest Google plusIndications
For which patients is Gilenya ® used?
GILENYA ® (fingolimod) is indicated as single disease modifying therapy in highly active relapsing remitting multiple sclerosis for the following groups of...
Twitter Linkedin Facebook Pinterest Google plusPathology
Patient Resources
Patient information leaflet ExjadeThe official patient information leaflet for EXJADE contains important information about its use and possible side effects. Patients can ask for the patient information leaflet at any time and...
Twitter Linkedin Facebook Pinterest Google plusReimbursement/eHealth
Safety Profile
Below is a selection of the observed side effects; please refer to the SmPc or the package leaflet for the complete list.
Myelosuppression
Patients who develop anaemia may need blood transfusions. Dose adjustment or...Twitter Linkedin Facebook Pinterest Google plusEfficacy
×